Home » Newsletters » The Carlat Addiction Treatment Report

The Carlat Addiction Treatment Report

Smoking Cessation (January/February) | 2022

View Archived Issues

Learning Objectives, Smoking Cessation, CATR, January/February 2022

January 18, 2022

After reading these articles, you should be able to… Read More

A Primer on Vaping: 15 Years On

January 18, 2022

Sivabalaji Kaliamurthy, MD

E-cigarettes entered the American market 15 years ago and their use has grown steadily ever since. Dr. Kaliamurthy starts with an overview of vaping technologies, then moves on to discuss the evidence for e-cigarettes as a smoking cessation tool, the new trend of vaping cannabis, and vaping associated health risks. Read More

Using Smoking Cessation Medications in Patients With Mental Illness

January 18, 2022

Michael Weaver, MD, FASAM.

Helping patients with mental illness quit smoking can be particularly challenging; however, there are evidenced based strategies that can help. In this article, we review the evidence for smoking cessation medications in patients with mental illness and highlight some important special considerations. Read More

Antipsychotics for Methamphetamine Psychosis

January 18, 2022

Sanya Virani, MD.

In this network meta-analysis, researchers compared different antipsychotics head-to-head for the treatment of methamphetamine psychosis and found some clear winners are losers. Read More

Meds for Alcohol Use Disorders

January 18, 2022

Mikveh Warshaw, NP.

Naltrexone has shown efficacy for the treatment of alcohol use disorder in tightly controlled trials. Here, researchers demonstrate the efficacy of naltrexone in a large scale naturalistic study. Read More